Scientists are researching if a drug that’s being tested to treat a skin condition can also help keep COVID-19 patients off ventilators. The drug, labeled as EDP1815, was being tested on psoriasis patients, but Dr. Reynold Panettieri, vice chancellor for translational medicine and science at Rutgers University, said it will now be tested on coronavirus patients who have pneumonia and inflammation of the lungs. To read the full article.
Recent Posts
- Health Policy Experts Identify Promising Strategies for Providing Health Care to Homeless People.
- NIH F Grant Writing Workshop 4/30 – Register by 4/27
- The Research that Got Sick Veterans Treatment.
- NJIT AI Researcher Makes Small Language Models Accessible.
- Tackling the Silent Threat of Inherited Heart Disease.
Categories
- Community (2,470)
- Covid (998)
- CTO Events (6)
- News (3,131)
- Pilots (21)